RPRX
Royalty Pharma plc · Healthcare · Medical - Pharmaceuticals
Momentum-inputs (vergelijkbare managers):
breedte van houders +14.3% ·
aandelenstroom +6.6% ·
netto nieuwe posities +12.5%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 146 | 0 | 306.62M | $17.19B | +5 | −4 |
| Q1 2026 | 148 | +6 | 297.67M | $14.26B | +10 | −5 |
| Q4 2025 | 141 | +1 | 305.31M | $11.80B | +2 | — |
| Q3 2025 | 19 | +1 | 173.40M | $6.12B | +2 | −2 |
| Q2 2025 | 16 | 0 | 158.26M | $5.71B | — | — |
| Q1 2025 | 13 | -3 | 61.13M | $1.91B | — | −3 |
| Q4 2024 | 16 | +2 | 77.30M | $1.97B | +2 | — |
| Q3 2024 | 13 | -1 | 62.78M | $1.78B | +1 | −2 |
| Q2 2024 | 14 | — | 58.59M | $1.54B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 16.97M | +42.6% | $432.86M | 0.8% | ▲ Add | 3 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 14.13M | -12.3% | $360.57M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 14.13M | -12.3% | $360.57M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 14.13M | -12.3% | $360.57M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 14.13M | -12.3% | $360.57M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 6 | Viking Global Investors ✦ | 12.21M | +0.9% | $311.42M | 1.0% | ▲ Add | 3 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passief) | 9.76M | — | $248.95M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passief) | 7.31M | +0.6% | $186.85M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passief) | 7.31M | +0.6% | $186.85M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (passief) | 4.88M | +1.5% | $124.50M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 2.90M | Nieuw | $73.93M | 0.1% | New | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 2.90M | Nieuw | $73.93M | 0.1% | New | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 2.42M | -0.4% | $61.74M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 2.42M | -44.4% | $61.61M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.90M | +187.0% | $48.56M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 1.90M | +187.0% | $48.56M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 1.90M | +187.0% | $48.56M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 1.90M | +187.0% | $48.56M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 1.90M | +187.0% | $48.56M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 1.90M | +187.0% | $48.56M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 1.16M | +24.6% | $29.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 669.88K | -51.8% | $17.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Point72 Asset Management ✦ | 249.00K | -52.7% | $6.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | T. Rowe Price ✦ | 246.45K | -13.9% | $6.29M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Bridgewater Associates ✦ | 49.42K | Nieuw | $1.26M | 0.0% | New | 1 | SEC ↗ |
| 26 | Wellington Management ✦ | 18.54K | +4.1% | $472,931 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 27 | Wellington Management ✦ | 18.54K | +4.1% | $472,931 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | Wellington Management ✦ | 18.54K | +4.1% | $472,931 | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Citadel Advisors | $73.93M | 0.1% |
| Citadel Advisors | $73.93M | 0.1% |
| Bridgewater Associates | $1.26M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 583 houders, 354.58M aandelen, $16.55B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 100.00K aand · $6.00M
Officer · 9.23K aand · $540,752
Officer · 1.77K aand · $104,799
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
18.7% van klasse · Originele SEC-indiening bekijken ↗
4.8% van klasse · Originele SEC-indiening bekijken ↗